Protalix BioTherapeutics
PLX
#7551
Rank
$82.84 M
Marketcap
$1.13
Share price
-0.88%
Change (1 day)
-47.20%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2023 (TTM): $11.75 M

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are $9.69 M. an increase over its 2022 earnings that were of -$11.87 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 2001 to 2023

Annual earnings

Year Earnings Change
2023 $11.75 M-199.05%
2022 -$11.87 M-40.38%
2021 -$19.91 M-732.31%
2020 $3.14 M-130.53%
2019 -$10.31 M189.85%
2018 -$3.56 M-95.29%
2017 -$75.55 M308.12%
2016 -$18.52 M-32.37%
2015 -$27.38 M10.11%
2014 -$24.86 M-7.59%
2013 -$26.9 M
2011 -$31.15 M-19.39%
2010 -$38.65 M20.87%
2009 -$31.97 M32.26%
2008 -$24.18 M-5.46%
2007 -$25.57 M
2004 -$0.17 M12.35%
2003 -$0.15 M-11.1%
2002 -$0.17 M-57.03%
2001 -$0.39 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$0.89 B 9,077.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.47 B 4,794.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.15 B-1,548.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.18 B 1,817.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel